Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
A very good place to experience a lot and move at a fast pace; however, often frustrating due to lack of focus on main objectives for the company.
¿Qué es lo mejor de tu paquéte de compensación?
It is competitive with industry standards
Revisión
¿Qué es lo que más te gusta de tu equipo directivo?
Open minded to alternative approaches and collaborative across functions
Revisión
¿Qué son algunas de las mejores cosas de tu equipo?
Very collaborative and talented group
Revisión
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
Coworkers are friendly and talented
Revisión
¿Qué va mal y cómo puede mejorarse?
Inconsistent goals and constantly shifting priorities by the day. Management rushes too much to push multiple objectives forward which results in work that often must be repeated or adjusted. More focus is needed to focus on a clear set of objectives.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×